ADDEX THERAPEUTICS LTD (ADXN) Stock Income Statement
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 643.00K | 410.00K | 1.62M | 1.45M | 3.15M | |||
| Operating Expenses | 2.82M | 3.17M | 3.86M | 21.97M | 18.66M | |||
| Research and Development | 687.30K | 851.20K | 1.16M | 14.64M | 12.82M | |||
| Selling, General, and Administrative Expenses | 1.97M | 2.31M | 2.67M | 7.29M | 5.81M | |||
| Operating Income | -2.18M | -2.76M | -2.24M | -20.52M | -15.51M | |||
| Interest Income/Expense | -3.07M | -2.15M | -257.20K | -284.00K | 308.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -220.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -5.25M | -4.91M | -2.50M | -20.80M | -15.20M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | 9.07M | 7.06M | -10.56M | -20.80M | -15.20M | |||
| EBITDA | -1.99M | -2.50M | -1.94M | -20.20M | -15.16M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 8.41 | 6.44 | -12.88 | -42.36 | -40.98 | |||
| Non GAAP EPS | N/A | N/A | N/A | -9.54 | N/A | |||
| Statistics | ||||||||
| Profit Margin | 1410.05% | 1720.93% | -652.75% | -1439.74% | -481.97% | |||
| Operating Profit Margin | -338.54% | -672.00% | -138.70% | -1420.08% | -491.74% | |||
All data in CHF